Free press releases distribution network?

Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Octagon Research Solutions, Inc. and Virtify, Inc. Announce Strategic Partnership - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc. a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced a strategic partnership with Virtify, Inc. of Cambridge, MA.
Octagon Research Solutions, Inc. and Virtify, Inc. Announce Strategic Partnership

 

PRZOOM - /newswire/ - Wayne, PA, United States, 2006/05/15 - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc. a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced a strategic partnership with Virtify, Inc. of Cambridge, MA..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

– CEO & Chairman Jim Walker of Octagon Research Solutions, Inc. a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced a strategic partnership with Virtify, Inc. of Cambridge, MA, a premium provider of information technology related products and solutions to the Life Sciences market. This new marketing partnership and venture will enable Octagon and Virtify to pair domain expertise with innovative technology solutions for the life sciences industry.

This marketing partnership is based on the concept that technology and domain expertise are codependent forces that are essential to the development of breakthrough improvements in research and development processes. Satish Tadikonda, President of Virtify noted, “Virtify’s product portfolio continues to expand to address the changing needs of the life sciences industry, especially in the clinical, regulatory and commercialization areas. Our partnership with Octagon will enable us to broaden our reach and secure market share in a complex and evolving marketplace.”

Jim Walker, Chairman and CEO of Octagon added, “We are very excited about the new partnership with Virtify. We are already using Virtify’s virtx:spl Global Labeling Solution to facilitate our SPL conversion service, and have developed a strong partnership that extends to global labeling initiatives and the capabilities required to support them. We are looking forward to a very successful partnership with Virtify.”

Joint marketing activities included in the partnership consist of educational programs, webinars and other promotional opportunities currently being developed under the partnership arrangement. These activities are expected to address a continuing need for education and broader understanding of emerging standards such as Regulated Product Submissions and regulations such as the Physicians Labeling Rule.

About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA, Costa Mesa, CA, and European headquarters in Amersham, UK.

About Virtify, Inc.
Virtify is a premium provider of information technology related products and solutions to the Life Sciences market. Virtify’s product portfolio includes products to support the clinical and regulatory activities at Life Sciences companies. Virtify also develops high-quality custom information technology solutions for its clients helping them improve their product and project management processes. These products and solutions help its clients accelerate their decision-making process and greatly reduce time-to-market. Virtify's product portfolio includes the Global Labeling Solution and the Virtify Investigator Database, a tool to help companies manage clinical trials efficiently. An example of a solution is an ongoing engagement with a multinational pharmaceutical company where Virtify is developing and implementing a web-based enterprise, 21 CFR Part 11 compliant, electronic-records management system that allows authorized users to track and manage key regulatory information and milestones. Virtify is headquartered in Cambridge, MA and has other international development and product support centers.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon Research Solutions, Inc. and Virtify, Inc. Announce Strategic Partnership

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Jim Graham 
610 535 6500 ext 5655 jgraham[.]octagonresearch.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.

Visit  MagLar, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today